Green Plains Inc. (GPRE) Market Cap & Valuation Ratios
Green Plains Inc. (GPRE) has a market cap of $979.9M, a trailing P/E of 9.1 and a price-to-sales ratio of 0.5, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
GPREGreen Plains Inc.Follow GPRE — free
—
Price chart with a free account
- Market cap
- 979.9M
- P/E TTM
- 9.1
- Dividend yield
- 0.2%
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
Peers
chemicals · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| GPRE | 1.0 | 9.1 | 0.7 | 5.5 | 13.0% | -24% | 7% | 9% |
| STDN | 1.9 | — | — | — | — | — | -91% | — |
| OLN | 1.8 | — | 0.7 | 11.8 | 5.6% | +0.6% | -2% | -2% |
| HUN | 1.5 | — | 0.6 | 12.4 | -0.6% | +0.6% | -0.5% | -0.7% |
| REX | 1.3 | 10.9 | 1.4 | 5.2 | 5.2% | +1% | 25% | 29% |
| KRO | 0.9 | — | 0.7 | 47.2 | -4.5% | +3% | -2% | -2% |
| LXU | 0.7 | 19.8 | 1.4 | 6.4 | 12.1% | +22% | 10% | 6% |
| TROX | 0.6 | — | 1.2 | 40.3 | — | +4% | -7% | -5% |
| RYAM | 0.5 | — | 0.8 | 13.6 | -8.1% | -3% | -3% | -5% |
| ASIX | 0.4 | — | 0.4 | 9.6 | -6.1% | +3% | -0.7% | -1.0% |
| VHI | 0.4 | — | 0.4 | 5.3 | 15.5% | +3% | 4% | 4% |
| Median of these 10 | 15.3 | 0.7 | 11.8 | 2.3% | +3% | -1% | -1.0% |
P/E 9.1 vs. a peer median of 15.3; EV/Sales 0.7 vs. 0.7.
Growth vs. price
each dot a company · hover or tap for valuesSTDN and OLN and HUN and KRO and TROX and RYAM and ASIX and VHI have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Green Plains Inc. — questions
- What is Green Plains Inc.'s market cap?
- $979.9M.
- What is Green Plains Inc.'s P/E ratio?
- 9.1 on trailing twelve-month earnings to 2026-06-30.
- What is Green Plains Inc.'s price-to-sales ratio?
- 0.5.
Every figure on this page comes from Green Plains Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.